Back to Trades
Krishnan Suma
PresidentR&DDirector10% OwnerCIK 0001298711
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 5
- Buy transactions
- 0
- Sell transactions
- 36
- Companies
- 1
- Active
- 2025–2026
Krishnan Suma, President, R&D, Director, 10% Owner, has filed 5 SEC reports (2025–2026), all concentrated in Krystal Biotech, Inc. (KRYS), totaling $35.2M in disclosed volume. Weighing $0 bought versus $21.8M sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
5 loaded
| Jun 5 | KRYS Krystal Biotech, Inc. | Krishnan Suma | President, R&D, Director, 10% Owner | Sell | $7.7M |
| Mar 6 | KRYS Krystal Biotech, Inc. | Krishnan Suma | President, R&D, Director, 10% Owner | Sell | $6.6M |
| Mar 3 | KRYS Krystal Biotech, Inc. | Krishnan Suma | President, R&D, Director, 10% Owner | Exercise | $13.4M |
| Jul 16 | KRYS Krystal Biotech, Inc. | Krishnan Suma | President, R&D, Director, 10% Owner | Sell | $5.4M |
| Jul 11 | KRYS Krystal Biotech, Inc. | Krishnan Suma | President, R&D, Director, 10% Owner | Sell | $2.1M |
5 filings